MDXG has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MDXG has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, MiMedx Group's enterprise value is $1,070.6 Mil. MiMedx Group's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $334.5 Mil. Therefore, MiMedx Group's EV-to-Revenue for today is 3.20.
The historical rank and industry rank for MiMedx Group's EV-to-Revenue or its related term are showing as below:
During the past 13 years, the highest EV-to-Revenue of MiMedx Group was 19.21. The lowest was 0.34. And the median was 3.69.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2024-05-12), MiMedx Group's stock price is $7.45. MiMedx Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $2.55. Therefore, MiMedx Group's PS Ratio for today is 2.93.
The historical data trend for MiMedx Group's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MiMedx Group Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
EV-to-Revenue | Get a 7-Day Free Trial | 2.80 | 3.86 | 2.63 | 1.12 | 3.88 |
MiMedx Group Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
EV-to-Revenue | Get a 7-Day Free Trial | 1.36 | 2.53 | 2.64 | 3.88 | 3.31 |
For the Biotechnology subindustry, MiMedx Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, MiMedx Group's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where MiMedx Group's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
MiMedx Group's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 1070.615 | / | 334.51 | |
= | 3.20 |
MiMedx Group's current Enterprise Value is $1,070.6 Mil.
MiMedx Group's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $334.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MiMedx Group (NAS:MDXG) EV-to-Revenue Explanation
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
MiMedx Group's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 7.45 | / | 2.545 | |
= | 2.93 |
MiMedx Group's share price for today is $7.45.
MiMedx Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.55.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of MiMedx Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Rice Doug | officer: Chief Financial Officer | 3451 PLANO PARKWAY, LEWISVILLE TX 75056 |
Joseph H Capper | officer: Chief Executive Officer | BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355 |
Robert Benjamin Stein | officer: EVP, Research and Development | C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON MA 02421 |
Peter M Carlson | officer: Chief Financial Officer | BRIGHTHOUSE FINANCIAL, INC., 11225 NORTH COMMUNITY HOUSE ROAD, CHARLOTTE NC 28277 |
William Lawrence Phelan | officer: Chief Accounting Officer | 1775 WEST OAK COMMONS COURT NE, MARIETTA GA 30062 |
Hulse William Frank Iv | officer: General Counsel | 1775 WEST OAK COMMONS COURT NE, MARIETTA GA 30062 |
Ricci S Whitlow | officer: Chief Operating Officer | C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873 |
Rohit Kashyap | officer: EVP & Chief Commercial Officer | 8023 VANTAGE DRIVE, SAN ANTONIO TX 78230 |
Timothy R Wright | director, officer: Chief Executive Officer | C/O CURAXIS, 1004 CHAGFORD WAY, RALEIGH NC 27614 |
Mark Graves | officer: SVP & Chief Compliance Officer | 1775 WEST OAK COMMONS COURT, MARIETTA GA 30062 |
Scott M Turner | officer: SVP, Operations & Procurement | 1775 WEST OAK COMMONS COURT, MARIETTA GA 30062 |
Phyllis Gardner | director | 618 MIRADA AVENUE, STANFORD CA 94305 |
Michael J Giuliani | director | 1775 WEST OAK COMMONS COURT NE, MARIETTA GA 30062 |
Cato T Laurencin | director | C/O UNIVERSITY OF CONNECTICUT, 263 FARMINGTON AVENUE, FARMINGTON CT 06030-3800 |
William A Hawkins | director | MEDTRONIC INC, 710 MEDTRONIC PKWY, MS LC310, MINNEAPOLIS MN 55432-5604 |
From GuruFocus
By Marketwired • 07-05-2023
By Marketwired • 08-01-2023
By Stock market mentor Stock market mentor • 01-03-2023
By Stock market mentor Stock market mentor • 01-30-2023
By PRNewswire • 01-23-2024
By Business Wire • 01-12-2024
By GlobeNewswire • 12-29-2023
By GuruFocus Research • 10-30-2023
By Marketwired • 07-18-2023
By sperokesalga sperokesalga • 03-23-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.